Olukemi Olugemo - 03 Jun 2024 Form 4 Insider Report for Korro Bio, Inc. (KRRO)

Reporting relationship: Chief Medical Officer
Issuer ticker: KRRO
Reported as of: 03 Jun 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2024, 19:12:33 UTC
Prior SEC filing: 14 May 2024
Next SEC filing: 05 Feb 2025
Source filing: View source filing
Reporting owner signature: /s/ Shelby Walker, Attorney-in-fact

Key filing fact

Olukemi Olugemo filed Form 4 for Korro Bio, Inc. (KRRO) on 04 Jun 2024.

Key facts

This page summarizes Olukemi Olugemo's Form 4 filing for Korro Bio, Inc. (KRRO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2024, 19:12.

Change

Previous filing in this sequence was filed on 14 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KRRO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +65,000
Change %
Price: $0.000000
Shares after: 65,000
Date: 03 Jun 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 65,000
Exercise price: $50.48
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option vest as to 25% of the shares on May 13, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.